CRISPR–Cas12-based detection of SARS-CoV-2

…, V Servellita, J Singh, X Miao, JA Streithorst… - Nature …, 2020 - nature.com
An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in
Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 …

[PDF][PDF] Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

…, J Cheng, J Balcerek, J Taylor, JA Streithorst… - Cell, 2021 - cell.com
We identified an emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples …

[HTML][HTML] Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation

…, J Cheng, J Balcerek, J Taylor, JA Streithorst… - MedRxiv, 2021 - ncbi.nlm.nih.gov
We identified a novel SARS-CoV-2 variant by viral whole-genome sequencing of 2,172
nasal/nasopharyngeal swab samples from 44 counties in California. Named B. 1.427/B. 1.429 to …

[HTML][HTML] Rapid detection of 2019 novel coronavirus SARS-CoV-2 using a CRISPR-based DETECTR lateral flow assay

…, X Deng, G Yu, CL Fasching, J Singh, J Streithorst… - MedRxiv, 2020 - ncbi.nlm.nih.gov
An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in
Wuhan, China in December 2019 and the COVID-19 disease associated with infection has …

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

…, KR Reyes, D Glasner, X Deng, J Streithorst… - Nature …, 2022 - nature.com
Associations between vaccine breakthrough cases and infection by different SARS coronavirus
2 (SARS-CoV-2) variants have remained largely unexplored. Here we analysed SARS-…

COVID-19 variant detection with a high-fidelity CRISPR-Cas12 enzyme

…, B Wang, N Brazer, K Reyes, J Streithorst… - Journal of Clinical …, 2022 - Am Soc Microbiol
Laboratory tests for the accurate and rapid identification of SARS-CoV-2 variants can potentially
guide the treatment of COVID-19 patients and inform infection control and public health …

Rapid deployment of SARS-CoV-2 testing: The CLIAHUB

…, M Sheehy, J Sheu, S Silas, JA Streithorst… - PLoS …, 2020 - journals.plos.org
Accurate diagnostic testing is at the center of controlling infectious disease outbreaks. It allows
clinicians and public health practitioners to identify and treat infected individuals as well …

Differentiation enhances Zika virus infection of neuronal brain cells

C Sánchez-San Martín, T Li, J Bouquet, J Streithorst… - Scientific reports, 2018 - nature.com
Zika virus (ZIKV) is an emerging, mosquito-borne pathogen associated with a widespread
2015–2016 epidemic in the Western Hemisphere and a proven cause of microcephaly and …

[PDF][PDF] Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C

…, AP Cheng, A Bliss, P Saldhi, N Brazer, J Streithorst… - Cell Reports …, 2023 - cell.com
Differential host responses in coronavirus disease 2019 (COVID-19) and multisystem
inflammatory syndrome in children (MIS-C) remain poorly characterized. Here, we use next-…

Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery

JK Tan, V Servellita, D Stryke, E Kelly, J Streithorst… - medRxiv, 2024 - medrxiv.org
Tools for rapid identification of novel and/or emerging viruses are urgently needed for clinical
diagnosis of unexplained infections and pandemic preparedness. Here we developed and …